Forbes
Search documents
Buy Or Sell IonQ Stock?
Forbes· 2025-11-04 16:31
Core Insights - IonQ is a prominent player in the quantum computing sector, currently facing challenges in achieving consistent profitability despite a strong revenue growth of 67.8% over the last 12 months [5][6] - The stock has experienced a significant decline of 20.3% over 21 trading days, raising concerns about its downturn resilience and potential for recovery [2][6] - IonQ's stock performance has lagged behind the S&P 500 during economic downturns, indicating a need for cautious investment strategies [2][6] Company Overview - IonQ is valued at $15 billion with a current trading price of $58.40 and reported revenue of $52 million [5] - The company provides general-purpose quantum computing systems accessible through major cloud platforms such as AWS, Microsoft Azure, and Google Cloud Marketplace [4] Financial Metrics - IonQ's operating margin stands at -700.6%, and it has a P/E multiple of -31.6, indicating challenges in profitability [5] - The company maintains a Debt to Equity ratio of 0.0 and a Cash to Assets ratio of 0.4, reflecting a strong liquidity position [5] Historical Performance - IonQ's stock saw a dramatic decline of 90.0% from a high of $31.00 in November 2021 to $3.10 in December 2022, compared to a 25.4% decline for the S&P 500 during the same period [6] - The stock fully recovered its pre-Crisis peak by November 2024 and reached a high of $82.09 in October 2025, currently trading at $58.40 [6] Investment Strategy - The Trefis High Quality Portfolio, which includes 30 stocks, has historically outperformed major indices, suggesting a diversified investment approach may yield better results than investing in individual stocks like IonQ [3][7]
Tesla Stock Drops Before Shareholder Meeting As Major Investor Plans Vote Against Musk Pay Plan
Forbes· 2025-11-04 16:15
Core Viewpoint - Tesla's stock experienced a decline of 2.6% following the announcement from Norway's sovereign wealth fund regarding its intention to vote against a substantial pay package for CEO Elon Musk, which could amount to $1 trillion [1]. Group 1 - Norway's sovereign wealth fund holds a 1.14% stake in Tesla [1]. - The fund's decision to vote against Musk's pay package is scheduled for Thursday [1]. - The proposed pay package for Musk has a potential value of $1 trillion [1].
This ‘Trump Insider' Is The Real Reason Stocks Keep Rising
Forbes· 2025-11-04 16:05
Core Viewpoint - The U.S. Treasury Secretary Scott Bessent is expected to announce new sanctions against Russia, indicating a strong stance from the U.S. government amidst ongoing geopolitical tensions [2] Group 1: Market Impact - Bessent's presence is seen as a stabilizing force for the stock market, with his bullish attitude contributing to a positive market sentiment [3][9] - The stock market has experienced a 15% return since Bessent's confirmation, suggesting that his influence may provide a safety net during market downturns [11] Group 2: Investment Opportunities - The article suggests that stock-focused closed-end funds (CEFs) are currently attractive investments, particularly those trading at discounts, such as the Liberty All-Star Growth Fund (ASG) which offers an 8.5% dividend yield [12][15] - ASG has a strong long-term performance, up 195% over the last decade, and is currently trading at a 9.3% discount to NAV, presenting additional upside potential [14][15]
Nintendo Switch 2 Is Selling Twice As Fast As Original Switch—Shattering Expectations Despite Trump Tariffs
Forbes· 2025-11-04 15:30
Core Insights - The Nintendo Switch 2 has sold over 10 million units in its first four months, significantly surpassing its predecessor's sales pace [2][3] - Nintendo has raised its sales forecast for the Switch 2 to 19 million units by March 2026, up from an earlier estimate of 15 million [2] - The Switch 2 is selling at a price of $450, which is a 50% increase compared to the original Switch's launch price [6] Sales Performance - The Switch 2 achieved sales of 10.36 million units since its launch on June 5, 2023, compared to 4.7 million units for the original Switch in the same timeframe [2] - The Switch 2 is recognized as the fastest-selling gaming console of all time, with over 3.5 million units sold within the first four days of its release [3] Market Dynamics - Analysts suggest that the higher price of the Switch 2 may have been influenced by tariffs imposed by the Trump administration, which affected manufacturing costs [6] - Despite the price increase, consumer confidence remains strong, indicating brand loyalty and demand for the Switch 2 [4] Game Sales - Over 20 million games for the Switch 2 have been sold in the first four months, with notable titles like "Mario Kart World" and "Donkey Kong Bananza" contributing to these figures [5] - Approximately 8 million of the game units sold were bundled with the Switch 2 consoles [5] Competitive Landscape - The original Nintendo Switch is nearing the sales figures of the Nintendo DS, with 154.01 million units sold, just shy of the DS's 154.02 million [7] - The Switch has the potential to surpass Sony's PlayStation 2, which holds the record for the best-selling console at 160 million units [7]
Palantir Plummets 8% Despite Beating Earnings Expectations—As Markets Stumble
Forbes· 2025-11-04 15:30
Core Insights - Palantir's stock experienced a significant decline of 8.1% to approximately $190 shortly after market open, marking its largest single-day drop since August [2] - The decline in Palantir's stock contributed to a broader market downturn, with the Nasdaq index falling by 0.9% and other major tech stocks also experiencing losses [2][3] - Despite reporting better-than-expected quarterly revenues of $1.18 billion and earnings per share of $0.21, Palantir's stock still faced downward pressure, indicating potential "rally exhaustion" in the market [1][3] Financial Performance - Palantir reported quarterly revenues of $1.18 billion, exceeding estimates of $1.09 billion [3] - The company's earnings per share were $0.21, surpassing the expected $0.17 [3] - Palantir raised its revenue forecast for the current quarter to $1.33 billion, above the previous projection of $1.19 billion [3] Market Context - The broader market saw declines, with the Dow Jones Industrial Average and S&P 500 dropping by 0.3% and 0.6%, respectively [3] - Major tech companies such as Nvidia, Boeing, Apple, and Cisco also reported stock declines, contributing to the overall market downturn [3]
Gold Rush: Buy Or Sell Newmont Stock?
Forbes· 2025-11-04 15:17
SEOUL, REPUBLIC OF KOREA: Gold bars are displayed at Shinhan Bank in Seoul on 09 January 2004. Gold prices hit 544.60 dollars per ounce on January 09, 2006, the highest level since January 1981, owing to geopolitical tensions in the Middle East and reports that China may increase its reserves of the metal. "Geopolitical tensions continue to provide reasons to be positive on gold, with deteriorating situations in both Iran and Iraq, while the possibility of Israels Prime Minister Ariel Sharon not returning ...
Purpose In The Pressure: Catherine Dargan On Building Billion-Dollar Deals
Forbes· 2025-11-04 15:05
Core Insights - Catherine Dargan, a partner at Covington, is recognized for her leadership in multibillion-dollar mergers and acquisitions, particularly in the life sciences sector [1][2] - Dargan has built a premier M&A practice over 25 years, representing major clients like Merck and Novartis, and has led significant deals such as Novartis' $12 billion acquisition of Avidity Biosciences [2] - The M&A landscape is expected to remain active despite external challenges, with a focus on acquiring innovative products in medical, technology, and AI sectors [3] Company Overview - Covington's Corporate Practice, under Dargan's leadership, has a strong regulatory background that benefits its life sciences niche [2] - The firm emphasizes collaboration and expertise to help clients navigate risks in an uncertain economic environment [4] Industry Trends - There is tight competition for innovative products, prompting companies to pursue acquisitions proactively [3] - Dargan's role extends beyond legal counsel to being a trusted advisor for corporations considering megadeals [3][4]
Meet America’s Top M&A Lawyers 2025
Forbes· 2025-11-04 15:00
Core Insights - The article emphasizes the role of elite lawyers in the billion-dollar mergers and acquisitions (M&A) sector, highlighting their importance as trusted advisors who guide complex transactions that can transform industries [1][2][3] Group 1: M&A Environment - The M&A market is currently experiencing renewed momentum and cautious optimism, with a notable increase in global deal value by 20% compared to the first five months of 2024 [6] - North American deal volume year-to-date is reported at $1.2 trillion, indicating a significant recovery in the M&A landscape [6] - Despite a slow start to 2025, the deal environment has improved, with firms actively seeking to close transactions before year-end [6][7] Group 2: Lawyer Expertise and Relationships - Top M&A lawyers are characterized by their commitment to excellence, creativity, and the ability to navigate complex legal and business landscapes [2][3] - Building long-term relationships with clients is crucial in M&A, as it helps lawyers understand client motivations and concerns [4][5] - The best lawyers possess a deep understanding of both the law and their clients' businesses, allowing them to anticipate regulatory and shareholder reactions [3][4] Group 3: Notable Transactions - Significant transactions in 2025 include Hess Corporation's $60 billion sale to Chevron Corp. and Paramount Global's $28 billion merger with Skydance Media, LLC [8] - Other major deals include AT&T's pending $23 billion acquisition of wireless spectrum licenses from EchoStar and Volkswagen's $5.7 billion joint venture with Rivian [9][12] - The article highlights the complexity and scale of these transactions, showcasing the lawyers' roles in facilitating them [10][11] Group 4: Future Outlook and Diversity - The U.S. remains a prime location for M&A activity, with opportunities for growth and innovation across various sectors [12] - The M&A field is noted for its lack of diversity, with ongoing efforts to create opportunities for underrepresented groups [15][16] - The article expresses hope for increased diversity in the M&A sector, emphasizing the importance of mentorship and opportunity creation [16]
Intuitive Surgical Stock To $700?
Forbes· 2025-11-04 14:55
Core Insights - Intuitive Surgical (ISRG) has experienced significant stock performance, with a 20% increase over the last month, currently priced at $544.21, and a potential target of $699 [3][4] - The company has a market capitalization of $194 billion and is recognized for its innovative robotic surgical systems that enhance minimally invasive procedures [4] - The stock has shown strong operational performance and financial health, despite a very high valuation, making it attractive yet volatile [3][5] Financial Performance - Intuitive Surgical's revenues have grown by 22% over the last 12 months, increasing from $7.9 billion to $9.6 billion, with quarterly revenues rising by 22.9% to $2.5 billion [5] - The company has achieved an average top-line growth rate of 16.3% over the past three years [5] - In the last 12 months, ISRG reported an operating income of $2.8 billion, with an operating margin of 29.3% and a cash flow margin of 30.8%, generating nearly $3.0 billion in operating cash flow [9] Profitability and Financial Stability - Intuitive Surgical's net income for the same period was approximately $2.7 billion, resulting in a net margin of about 28.6% [9] - The company has no debt, leading to a Debt-to-Equity Ratio of 0.0%, and its cash (including cash equivalents) constitutes $4.9 billion of total assets of $19 billion, yielding a Cash-to-Assets Ratio of 25.4% [9] Market Resilience - ISRG has shown moderate resilience during economic downturns, experiencing a decline greater than the S&P 500 index during various market crises [6] - Historical data indicates that ISRG stock has fully recovered from significant declines, including a 49.9% drop from a high of $365.42 in November 2021 to $183.06 in October 2022, and a 75.9% drop from $39.32 in April 2008 to $9.48 in March 2009 [10]
Should You Buy GoodRx Stock?
Forbes· 2025-11-04 14:55
Core Insights - GoodRx (GDRX) stock is considered a viable investment due to its expansion, cash generation, and notable valuation discount [1] Financial Performance - GoodRx has a free cash flow yield of 10.0%, indicating strong cash generation capabilities [8] - Revenue growth over the last 12 months is 3.2%, suggesting potential for increased cash reserves [8] Valuation Metrics - GDRX stock is currently priced at 35% below its 3-month high, 46% under its 1-year high, and 63% lower than its 2-year high, highlighting a significant valuation discount [8] Market Trends - The stock has experienced substantial declines, including a 41% drop during the Covid pandemic and a nearly 93% decline during the inflation crisis, indicating vulnerability to market fluctuations [6] - Despite favorable aspects, the stock can still face considerable declines during market shifts [6] Investment Strategy - The average forward returns for GDRX over 6-month and 12-month periods are 25.7% and 57.9% respectively, with a win rate exceeding 70% for both intervals [9]